Daiichi Sankyo

About Daiichi Sankyo

Daiichi Sankyo is a global pharmaceutical company headquartered in Japan, with a significant presence in the UK. The company is dedicated to the research, development, and commercialization of innovative medicines that address unmet medical needs.

Founded in 2005 through the merger of Daiichi Pharmaceutical and Sankyo Company, Limited, Daiichi Sankyo has established itself as a leader in the pharmaceutical industry. The company focuses on several therapeutic areas, including oncology, cardiovascular diseases, and infectious diseases.

Core Activities:

• Research and Development: Daiichi Sankyo invests heavily in R&D to discover new drugs and improve existing therapies.
• Manufacturing: The company operates state-of-the-art manufacturing facilities to ensure high-quality production of its pharmaceutical products.
• Marketing and Sales: With a strong marketing strategy, Daiichi Sankyo effectively promotes its products to healthcare professionals and patients.

The company’s vision is to contribute to society by providing innovative solutions that enhance the quality of life for patients worldwide. Daiichi Sankyo is committed to sustainability and ethical practices, ensuring that its operations positively impact the communities it serves.

With a diverse workforce and a culture of collaboration, Daiichi Sankyo fosters an environment where creativity and innovation thrive. The company aims to be at the forefront of scientific advancements, continuously striving to bring new therapies to market.

In summary, Daiichi Sankyo is not just a pharmaceutical company; it is a partner in health, dedicated to making a difference in the lives of patients around the globe.